Literature DB >> 15889279

Familial X-linked cardiomyopathy (Danon disease): diagnostic confirmation by mutation analysis of the LAMP2gene.

Christian Balmer1, Diana Ballhausen, Nils U Bosshard, Beat Steinmann, Eugen Boltshauser, Urs Bauersfeld, Andrea Superti-Furga.   

Abstract

UNLABELLED: A boy presented at age 2.5 years with mild left ventricular hypertrophy and mild myopathy. Hypertrophic cardiomyopathy progressed relentlessly, leading to death at age 16 years shortly before planned heart transplantation. During the course of the disease, his mother developed severe dilated cardiomyopathy and died of its complications at 46 years of age. The combination of myopathy and cardiomyopathy, the biochemical and electron microscopy findings in a muscle biopsy, and the pedigree suggested Danon disease (MIM 300257), an X-linked lysosomal storage disorder caused by deficiency of lysosome-associated membrane protein-2 (LAMP2). The diagnosis was confirmed by the identification of a novel mutation, G138A, in the LAMP2gene, leading to the premature stop codon W46X.
CONCLUSION: Early diagnosis of Danon disease is important for genetic counselling and timely cardiac transplantation, the only effective therapeutic option.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15889279     DOI: 10.1007/s00431-005-1678-z

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  21 in total

1.  Germline mosaicism of a novel mutation in lysosome-associated membrane protein-2 deficiency (Danon disease).

Authors:  Maki Takahashi; Ayaka Yamamoto; Kyoko Takano; Akira Sudo; Takahito Wada; Yu-ichi Goto; Ichizo Nishino; Shinji Saitoh
Journal:  Ann Neurol       Date:  2002-07       Impact factor: 10.422

2.  A method for the colorimetric estimation of glycogen with iodine.

Authors:  C R KRISMAN
Journal:  Anal Biochem       Date:  1962-07       Impact factor: 3.365

3.  Dominantly inherited cardioskeletal myopathy with lysosomal glycogen storage and normal acid maltase levels.

Authors:  E Byrne; X Dennett; B Crotty; I Trounce; J M Sands; R Hawkins; J Hammond; S Anderson; E A Haan; A Pollard
Journal:  Brain       Date:  1986-06       Impact factor: 13.501

4.  Familial lethal cardiomyopathy with mental retardation and scapuloperoneal muscular dystrophy.

Authors:  B Bergia; H D Sybers; I J Butler
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-12       Impact factor: 10.154

Review 5.  Biogenesis of the lysosomal membrane.

Authors:  M Fukuda
Journal:  Subcell Biochem       Date:  1994

6.  Lysosomal glycogen storage disease with normal acid maltase.

Authors:  M J Danon; S J Oh; S DiMauro; J R Manaligod; A Eastwood; S Naidu; L H Schliselfeld
Journal:  Neurology       Date:  1981-01       Impact factor: 9.910

7.  Primary LAMP-2 deficiency causes X-linked vacuolar cardiomyopathy and myopathy (Danon disease).

Authors:  I Nishino; J Fu; K Tanji; T Yamada; S Shimojo; T Koori; M Mora; J E Riggs; S J Oh; Y Koga; C M Sue; A Yamamoto; N Murakami; S Shanske; E Byrne; E Bonilla; I Nonaka; S DiMauro; M Hirano
Journal:  Nature       Date:  2000-08-24       Impact factor: 49.962

Review 8.  Disease model: LAMP-2 enlightens Danon disease.

Authors:  P Saftig; Y Tanaka; R Lüllmann-Rauch; K von Figura
Journal:  Trends Mol Med       Date:  2001-01       Impact factor: 11.951

9.  Case report: lysosomal glycogen storage disease with normal acid maltase: an unusual form of hypertrophic cardiomyopathy with rapidly progressive heart failure.

Authors:  H F Tse; T W Shek; Y T Tai; Y K Lau; L Ma
Journal:  Am J Med Sci       Date:  1996-10       Impact factor: 2.378

Review 10.  Clinicopathological features of genetically confirmed Danon disease.

Authors:  K Sugie; A Yamamoto; K Murayama; S J Oh; M Takahashi; M Mora; J E Riggs; J Colomer; C Iturriaga; A Meloni; C Lamperti; S Saitoh; E Byrne; S DiMauro; I Nonaka; M Hirano; I Nishino
Journal:  Neurology       Date:  2002-06-25       Impact factor: 9.910

View more
  10 in total

1.  LAMP2 microdeletions in patients with Danon disease.

Authors:  Zhao Yang; Birgit H Funke; Linda H Cripe; G Wesley Vick; Debora Mancini-Dinardo; Liana S Peña; Ronald J Kanter; Brenda Wong; Brandy H Westerfield; Jaquelin J Varela; Yuxin Fan; Jeffrey A Towbin; Matteo Vatta
Journal:  Circ Cardiovasc Genet       Date:  2010-02-20

2.  Brief Report: Oxidative Stress Mediates Cardiomyocyte Apoptosis in a Human Model of Danon Disease and Heart Failure.

Authors:  Sherin I Hashem; Cynthia N Perry; Matthieu Bauer; Sangyoon Han; Stacey D Clegg; Kunfu Ouyang; Dekker C Deacon; Mary Spinharney; Athanasia D Panopoulos; Juan Carlos Izpisua Belmonte; Kelly A Frazer; Ju Chen; Qiuming Gong; Zhengfeng Zhou; Neil C Chi; Eric D Adler
Journal:  Stem Cells       Date:  2015-05-13       Impact factor: 6.277

3.  Danon disease: intrafamilial phenotypic variability related to a novel LAMP-2 mutation.

Authors:  Sarah-Louise Cottinet; Anne-Marie Bergemer-Fouquet; Annick Toutain; Frédérique Sabourdy; Zoha Maakaroun-Vermesse; Thierry Levade; Alain Chantepie; François Labarthe
Journal:  J Inherit Metab Dis       Date:  2010-12-16       Impact factor: 4.982

Review 4.  The renal Fanconi syndrome in cystinosis: pathogenic insights and therapeutic perspectives.

Authors:  Stephanie Cherqui; Pierre J Courtoy
Journal:  Nat Rev Nephrol       Date:  2016-12-19       Impact factor: 28.314

Review 5.  Danon disease: clinical features, evaluation, and management.

Authors:  Ryan S D'souza; Cecilia Levandowski; Dobromir Slavov; Sharon L Graw; Larry A Allen; Eric Adler; Luisa Mestroni; Matthew R G Taylor
Journal:  Circ Heart Fail       Date:  2014-09       Impact factor: 8.790

6.  Danon disease for the cardiologist: case report and review of the literature.

Authors:  Ryan S D'souza; Luisa Mestroni; Matthew R G Taylor
Journal:  J Community Hosp Intern Med Perspect       Date:  2017-06-06

7.  Cardiac disease in children and young adults with various lysosomal storage diseases: Comparison of echocardiographic and ECG changes among clinical groups.

Authors:  P Mueller; C H Attenhofer Jost; M Rohrbach; E R Valsangiacomo Buechel; B Seifert; C Balmer; O Kretschmar; M R Baumgartner; R Weber
Journal:  Int J Cardiol Heart Vessel       Date:  2013-11-13

Review 8.  Hypertrophic Cardiomyopathy in Children: Pathophysiology, Diagnosis, and Treatment of Non-sarcomeric Causes.

Authors:  Emanuele Monda; Marta Rubino; Michele Lioncino; Francesco Di Fraia; Roberta Pacileo; Federica Verrillo; Annapaola Cirillo; Martina Caiazza; Adelaide Fusco; Augusto Esposito; Fabio Fimiani; Giuseppe Palmiero; Giuseppe Pacileo; Paolo Calabrò; Maria Giovanna Russo; Giuseppe Limongelli
Journal:  Front Pediatr       Date:  2021-02-25       Impact factor: 3.569

Review 9.  Targeted Therapy in Cardiovascular Disease: A Precision Therapy Era.

Authors:  Mengda Xu; Jiangping Song
Journal:  Front Pharmacol       Date:  2021-04-16       Impact factor: 5.810

10.  Long-Term Follow-Up of Peripheral Pigmentary Retinopathy in Asian Patients with Danon Disease.

Authors:  Jee Myung Yang; Beom Hee Lee; Gi-Byoung Nam; June-Gone Kim; Joo Yong Lee
Journal:  Genes (Basel)       Date:  2020-11-16       Impact factor: 4.096

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.